Biotech News
Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results
delcathsystemsinc.gcs-web.com2026-05-06 15:11 EST
QUEENSBURY, N.Y. --(BUSINESS WIRE)--Jan. 9, 2026-- Delcath Systems, Inc. (Nasdaq: DCTH) (“Delcath” or the “Company”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced preliminary financial results and business updates for